首页> 外文期刊>海南医科大学学报(英文版) >Clinical effect of tiotropium bromide on pulmonary function,arterial blood gas and serum inflammatory cytokine in elderly patients with COPD at stable stage
【24h】

Clinical effect of tiotropium bromide on pulmonary function,arterial blood gas and serum inflammatory cytokine in elderly patients with COPD at stable stage

机译:噻托溴铵对老年COPD稳定期患者肺功能,动脉血气和血清炎性细胞因子的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To observe the clinical effect of tiotropium bromide in elderly patients with COPD at stable stage and its effects on pulmonary function,blood and serum inflammatory cytokine. Methods: 80 elderly patients with COPD s at stable stage were randomly divided into treatment group and control group with 40 patients in each group. The control group was treated with normal treatment. The treatment group was treated with tiotropium bromide on the basis of control group. 3 months after treatment, the pulmonary function、arterial blood gas and serum inflammatory cytokine were detected and compared in the two groups. Results:There was no significant difference in lung function index and TNF- alpha level between the two groups before treatment (P>0.05). The levels of FVC, FEV1% and PEF were increased and serum TNF-α was decreased significantly after treatment in two groups (P<0.05), and they were better than in treatment group than those in control group (all P<0.05); There was no significant difference in blood gas index between the two groups before treatment (P>0.05);In addition, there were no significant difference in the level of PCT, PaO2, PaCO2 and PaO2/FiO2 after treatment in control group, but the level of PCT and PaCO2 were higher and PaO2 and PaO2/FiO2 were lower obviously after treatment (P<0.01). The treatment group was superior to the control group (all P<0.05); Moreover, the curative effect of treatment group was better than that in control group (P<0.05). Conclusion: Tiotropium bromide can improve pulmonary function, pulmonary function、arterial blood gas and serum inflammatory cytokine in elderly stable COPD patients.
机译:目的:观察噻托溴铵对老年COPD患者稳定期的临床疗效及其对肺功能,血液和血清炎性细胞因子的影响。方法:将80例稳定期老年COPD患者随机分为治疗组和对照组,每组40例。对照组采用常规治疗。治疗组在对照组的基础上用噻托溴铵治疗。治疗3个月后,检测并比较两组肺功能,动脉血气和血清炎性细胞因子。结果:治疗前两组肺功能指数和TNF-α水平无显着性差异(P> 0.05)。两组治疗后FVC,FEV1%和PEF水平明显升高,血清TNF-α水平明显降低(P <0.05),均优于治疗组(P <0.05)。两组治疗前血气指标无显着性差异(P> 0.05);对照组治疗后PCT,PaO2,PaCO2和PaO2 / FiO2水平无显着性差异,但治疗后PCT和PaCO2水平较高,PaO2和PaO2 / FiO2水平明显降低(P <0.01)。治疗组优于对照组(均P <0.05)。此外,治疗组的疗效优于对照组(P <0.05)。结论:噻托溴铵可改善老年稳定型COPD患者的肺功能,肺功能,动脉血气和血清炎性细胞因子。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2018年第22期|9-12|共4页
  • 作者单位

    Infectious Diseases Department, Jiangxia First People's Hospital of Wuhan City, Wuhan, 430200, China;

    Infectious Diseases Department, Jiangxia First People's Hospital of Wuhan City, Wuhan, 430200, China;

    Infectious Diseases Department, Jiangxia First People's Hospital of Wuhan City, Wuhan, 430200, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号